Advertisement

Advertisement

JAZZ Stock Latest News

Jazz Pharmaceuticals Advances Cannabidiol Trial in Focal-Onset Seizures: What Investors Should Watch

Company AnnouncementsJazz Pharmaceuticals Advances Cannabidiol Trial in Focal-Onset Seizures: What Investors Should Watch

Jessica Fye Reaffirms Buy on Jazz Pharmaceuticals, Citing Blockbuster Potential for Zanidatamab in First-Line HER2-Positive Gastric and Esophageal Cancers

PremiumRatings

Jessica Fye Reaffirms Buy on Jazz Pharmaceuticals, Citing Blockbuster Potential for Zanidatamab in First-Line HER2-Positive Gastric and Esophageal Cancers

2d ago

Jazz Pharmaceuticals announces planned board leadership transition

PremiumCompany Announcements

Jazz Pharmaceuticals announces planned board leadership transition

5d ago

Jazz Pharmaceuticals Phase 3 HERIZON-GEA-01 results published in NEJM

PremiumThe Fly

Jazz Pharmaceuticals Phase 3 HERIZON-GEA-01 results published in NEJM

7d ago

Jazz Pharmaceuticals price target raised to $253 from $234 at Barclays

PremiumThe Fly

Jazz Pharmaceuticals price target raised to $253 from $234 at Barclays

8d ago

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

PremiumWeekend UpdatesCTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

12d ago

Texas Instruments, Generac upgraded: Wall Street’s top analyst calls

The Fly

Texas Instruments, Generac upgraded: Wall Street’s top analyst calls

12d ago

Jazz Pharmaceuticals price target raised to $301 from $232 at Piper Sandler

The Fly

Jazz Pharmaceuticals price target raised to $301 from $232 at Piper Sandler

13d ago

Bernstein starts Jazz at Market Perform, says clock ticking on blockbuster drugs

PremiumThe Fly

Bernstein starts Jazz at Market Perform, says clock ticking on blockbuster drugs

13d ago

Jazz Pharmaceuticals initiated with a Market Perform at Bernstein

PremiumThe Fly

Jazz Pharmaceuticals initiated with a Market Perform at Bernstein

13d ago

Jazz Pharmaceuticals Rides Record Q1 and Oncology Gains

PremiumCompany Announcements

Jazz Pharmaceuticals Rides Record Q1 and Oncology Gains

15d ago

Midday Fly By: Home Depot reports Q1 beat, Blackstone and Google form cloud JV

PremiumThe Fly

Midday Fly By: Home Depot reports Q1 beat, Blackstone and Google form cloud JV

15d ago

StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls

PremiumThe FlyStubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls

15d ago

Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS

The Fly

Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS

16d ago

Jazz Pharmaceuticals price target raised to $245 from $226 at Morgan Stanley

The Fly

Jazz Pharmaceuticals price target raised to $245 from $226 at Morgan Stanley

27d ago

ALX Oncology evorpacept combination data presented at ESMO congress

PremiumThe Fly

ALX Oncology evorpacept combination data presented at ESMO congress

27d ago

Jazz Pharmaceuticals price target raised to $234 from $225 at Barclays

PremiumThe Fly

Jazz Pharmaceuticals price target raised to $234 from $225 at Barclays

28d ago

Jazz Pharmaceuticals price target raised to $252 from $209 at Baird

PremiumThe Fly

Jazz Pharmaceuticals price target raised to $252 from $209 at Baird

28d ago

Jazz Pharmaceuticals price target raised to $275 from $220 at TD Cowen

PremiumThe Fly

Jazz Pharmaceuticals price target raised to $275 from $220 at TD Cowen

28d ago

Jazz Pharmaceuticals price target raised to $239 from $227 at Raymond James

PremiumThe FlyJazz Pharmaceuticals price target raised to $239 from $227 at Raymond James

28d ago

Jazz Pharmaceuticals Signals Confidence After Record Quarter

Company Announcements

Jazz Pharmaceuticals Signals Confidence After Record Quarter

28d ago

Jazz Pharmaceuticals reports Q1 adjusted EPS $6.34, consensus $4.66

The Fly

Jazz Pharmaceuticals reports Q1 adjusted EPS $6.34, consensus $4.66

29d ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >